cyclopropyl(1-methyl-1H-1,2,4-triazol-5-yl)methanone, 95.0%, 10g

6-Methyl-4-trifluoromethyl-pyridin-2-ol, 95.0%, 5g

1,3,5-Trimethylcyclohexane, 98.0%, 5g

4-Bromo-1-isopropoxy-2-methoxybenzene, 97%, 250mg

Estaño hexabutilditin 98+% 25 g

(diazyn-1-ium-1-yl)(4-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}butyl)azanide, 100mg

Imidazo[1,2-a]pyridin-8-ol, 95.0%, 5g

Methyl (Phenyl 5-Acetoxyacetamido-4,7,8-tri-O-acetyl-9-azido-3,5,9-trideoxy-2-thio-D-glycero-beta-D-galacto-2-nonulopyranosid)onate>93.0%(HPLC)100mg

Ethyl 2-(methylamino)benzoate, 95.0%, 100mg

(S)-2-Chloro-7-(1-methoxyethyl)pyrazolo[1,5-a]pyrimidine-6-carboxylic acid, 98%, 1g

1-(2-Nitrophenyl)ethanol, 95.0%, 25g

TARIQUIDAR, 95%, 1mg

14-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)-3,6,9,12-TETRAOXATETRADECANOIC ACID, 95%, 250mg